LymphoSign Journal-The Journal of Inherited Immune Disorders

Scope & Guideline

Exploring Innovations in Immunology

Introduction

Immerse yourself in the scholarly insights of LymphoSign Journal-The Journal of Inherited Immune Disorders with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2292-5937
PublisherLYMPHOSIGN JOURNAL LTD PARTNERSHIP
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationLYMPHOSIGN J / LynphoSign J.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 361, BIRMINGHAM, AL 35283-0399

Aims and Scopes

The LymphoSign Journal focuses on advancing the understanding of inherited immune disorders and their clinical implications. The journal serves as a platform for disseminating research findings that enhance the diagnosis, treatment, and management of primary immunodeficiencies and related conditions.
  1. Primary Immunodeficiencies:
    The journal emphasizes research on various primary immunodeficiencies, including their genetic underpinnings, clinical manifestations, and management strategies.
  2. Genetic Mutations and Variants:
    A significant focus is on identifying novel genetic mutations associated with immune disorders, contributing to the understanding of disease mechanisms and potential therapeutic targets.
  3. Clinical Outcomes and Management:
    Research on clinical outcomes in patients with inherited immune disorders, including treatment responses and management protocols, is a core area of interest.
  4. Neurodevelopmental Impacts:
    Exploration of the neurodevelopmental aspects associated with immune disorders, understanding how these conditions affect cognitive and physical development.
  5. Public Health and Epidemiology:
    The journal addresses broader public health implications, including the impact of infectious diseases like COVID-19 on individuals with immune deficiencies.
  6. Patient Perspectives and Resources:
    It also highlights the importance of patient perspectives, data sharing, and resources for individuals affected by primary immunodeficiency.
Recent publications in the LymphoSign Journal reflect a dynamic shift towards emerging themes and trending topics that address contemporary challenges in the field of inherited immune disorders. These themes indicate a growing interest in precision medicine, genetic research, and the impact of global health events on immunodeficiency.
  1. Impact of COVID-19 on Immunodeficiency:
    There is a notable trend in exploring the effects of COVID-19 on patients with primary immunodeficiencies, including treatment responses and long-term outcomes.
  2. Novel Genetic Discoveries:
    The identification of novel genetic mutations and variants is increasingly emphasized, showcasing the journal's commitment to advancing genetic research in immune disorders.
  3. Multisystem Inflammatory Syndromes:
    Research on multisystem inflammatory syndromes, particularly in the context of COVID-19, has emerged as a significant theme, reflecting its relevance in pediatric and adult populations.
  4. Patient-Centric Research:
    The journal is increasingly focusing on perspectives from patients and families affected by primary immunodeficiencies, highlighting the importance of community engagement and support.
  5. Algorithm Development for Screening and Management:
    Recent publications indicate a trend towards developing algorithms for newborn screening and management of severe combined immunodeficiency, aiming for early detection and intervention.

Declining or Waning

While the journal has consistently focused on several core themes, certain areas have seen a decline in prominence over recent years. This may indicate a shift in research priorities or emerging interests in other aspects of immunology.
  1. General Immunodeficiency Discussions:
    Broad discussions on immunodeficiencies that do not focus on specific conditions or genetic mutations have become less frequent, as the journal narrows its focus towards more defined topics.
  2. Viral Infections and Immunodeficiency:
    Research specifically linking viral infections (other than COVID-19) with primary immunodeficiencies has seen a decrease, possibly due to the overwhelming focus on COVID-19 related studies.
  3. Traditional Treatment Protocols:
    Publications centered on established treatment protocols for immunodeficiencies have waned, as newer, innovative approaches and personalized medicine gain traction.

Similar Journals

Journal of Pediatric Genetics

Advancing Insights in Pediatric Genetics
Publisher: GEORG THIEME VERLAG KGISSN: 2146-4596Frequency: 4 issues/year

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.

JOURNAL OF INFECTIOUS DISEASES

Elevating Understanding in Immunology and Infectious Diseases
Publisher: OXFORD UNIV PRESS INCISSN: 0022-1899Frequency: 24 issues/year

The JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.

OPHTHALMIC GENETICS

Advancing the Frontiers of Vision and Genetics
Publisher: TAYLOR & FRANCIS INCISSN: 1381-6810Frequency: 4 issues/year

OPHTHALMIC GENETICS is a distinguished journal published by TAYLOR & FRANCIS INC, specializing in the intersection of genetics and ophthalmology. Established in 1981, the journal has become a vital resource for researchers, clinicians, and students interested in the genetic aspects of eye diseases and disorders. Despite not being an Open Access journal, it maintains a commendable impact within the academic community, as reflected by its Q3 ranking in clinical genetics and Q2 rankings in both ophthalmology and pediatrics in 2023. With a robust focus on clinical applications, OPHTHALMIC GENETICS aims to provide a platform for innovative research and insights that drive advancements in patient care and understanding of genetic conditions affecting vision. The journal's international readership is supported by its timely publication of articles that bridge the gap between genetic research and practical ophthalmological applications.

Turkish Journal of Immunology

Pioneering Insights in Immune Science
Publisher: GALENOS PUBL HOUSEISSN: 1301-109XFrequency: 3 issues/year

Turkish Journal of Immunology, published by GALENOS PUBL HOUSE, is a key platform for research in the field of immunology, with ISSN 1301-109X and E-ISSN 2147-8325. Established to foster the dissemination of original research, critical reviews, and cutting-edge developments, this journal spans a wide array of immunological topics, aiming to keep researchers, healthcare professionals, and students abreast of emergent trends and findings. Although classified in the Q4 quartile within both the Immunology and Allergy categories, the journal provides an essential venue for underrepresented research, paving the way for innovative ideas and collaborations. The editorial board emphasizes a rigorous peer-review process, ensuring the highest standards in the publication of quality science. For those keen to explore the intricacies of immunity, the Turkish Journal of Immunology is not to be missed.

Journal of Asthma and Allergy

Leading the way in allergy and asthma advancements.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6965Frequency: 1 issue/year

The Journal of Asthma and Allergy, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing research in the fields of immunology, allergy, and pulmonary medicine. Since its inception in 2008, this journal has provided a vital platform for disseminating high-quality, peer-reviewed research that explores the complexities of asthma and allergy, allowing researchers, professionals, and students to access critical insights without subscription barriers. With an impressive impact factor reflected in its 2023 quartile rankings (Q2) in both Immunology and Allergy, as well as Pulmonary and Respiratory Medicine, the journal stands as a significant contributor to the scientific community, promoting innovative findings that support clinical practice and patient care. Based in New Zealand, the Journal of Asthma and Allergy continues to be at the forefront of research, from its dedication to publishing cutting-edge studies to fostering an inclusive academic discourse that spans the globe. Access to relevant articles is available online, ensuring that all stakeholders in these fields can stay informed and engaged.

Molecular Genetics & Genomic Medicine

Exploring innovations in genetics and healthcare.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

Hematology

Exploring Blood Science: Bridging Knowledge and Practice
Publisher: TAYLOR & FRANCIS LTDISSN: 1024-5332Frequency: 1 issue/year

Hematology is a distinguished open-access journal published by Taylor & Francis Ltd, dedicated to advancing research and knowledge in the field of hematology. Established in 1996, the journal has continually evolved to meet the needs of a growing community of researchers and practitioners, providing a vital platform for disseminating innovative findings and clinical insights. With its impact factor reflecting a robust commitment to quality scholarship, Hematology has achieved a respectable position in its category as evidenced by its Q3 ranking in the Hematology category and ranks #85 out of 137 in the Scopus index, which positions it in the 38th percentile among its peers. The journal’s open-access policy, initiated in 2019, further enhances its reach and accessibility, allowing a broad audience of professionals, researchers, and students to engage with high-quality research without barriers. By covering a wide range of topics related to blood disorders, treatment methodologies, and emerging therapies, Hematology stands as an essential resource for those dedicated to innovation in this critical area of healthcare.

American Journal of Clinical and Experimental Immunology

Pioneering Research for a Healthier Tomorrow
Publisher: E-CENTURY PUBLISHING CORPISSN: Frequency: 6 issues/year

Welcome to the American Journal of Clinical and Experimental Immunology, a premier publication dedicated to advancing the fields of clinical and experimental immunology. Published by E-CENTURY PUBLISHING CORP, this journal provides a platform for groundbreaking research, case studies, and comprehensive reviews that contribute to our understanding of the immune system and its implications for health and disease. With a focus on disseminating innovative findings and enhancing the dialogue among researchers, practitioners, and students, the journal aims to bridge the gap between laboratory discoveries and clinical applications. Although specific metrics such as the impact factor and Scopus ranks are currently not provided, the journal is committed to maintaining high standards of scholarly publishing and fostering open access to vital research. Located in Madison, WI, and available online via its E-ISSN 2164-7712, this journal is a valuable resource for those wishing to explore the intricacies of immunological research and its applications in clinical practice.

CLINICAL IMMUNOLOGY

Fostering Innovation in Immunological Research
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1521-6616Frequency: 12 issues/year

CLINICAL IMMUNOLOGY is a premier academic journal dedicated to the field of immunology, published by Academic Press Inc. Elsevier Science. With a robust impact reflected in its recent categorization as Q2 in Immunology and Q1 in Immunology and Allergy for 2023, this journal stands out as a key resource for researchers and professionals alike. Featuring a diverse array of articles from fundamental laboratory studies to advanced clinical applications, CLINICAL IMMUNOLOGY aims to disseminate significant research findings that contribute to the evolving landscape of immunological science. Its notable Scopus rankings underscore its esteemed position, with ranks of #33 and #36 in the respective categories, highlighting its commitment to high-quality scholarly work. Although not an open-access journal, it ensures access to valuable insights and developments in the immune response and related fields, making it an indispensable tool for students and professionals aiming to stay at the forefront of immunological research.

BRITISH JOURNAL OF OPHTHALMOLOGY

Illuminating the Path to Better Vision
Publisher: BMJ PUBLISHING GROUPISSN: 0007-1161Frequency: 12 issues/year

The British Journal of Ophthalmology, published by the BMJ Publishing Group, stands as a leading peer-reviewed journal in the field of ocular sciences, with a distinctive focus on advancing the understanding of vision and its impairment. With a rich history dating back to 1941, this journal serves as an essential platform for researchers, professionals, and students in ophthalmology and related disciplines. It prominently ranks in the Q1 quartile for Ophthalmology and Cellular and Molecular Neuroscience in 2023, reflecting its esteemed reputation in the scientific community. The journal boasts impressive Scopus rankings, including Rank #6 in Medicine - Ophthalmology, showcasing its influential contributions to the field. Although it does not offer open access, the journal is committed to disseminating high-quality research that informs clinical practices and enriches the understanding of sensory systems. Submissions are encouraged from all areas of ophthalmology, including clinical studies, innovative research, and systemic reviews. Join the vibrant academic dialogue by engaging with the cutting-edge findings published in the British Journal of Ophthalmology, which aims to bridge the gap between research and clinical application.